HK1172830A1 - Ultrasound contrast agent dosage formulation - Google Patents
Ultrasound contrast agent dosage formulationInfo
- Publication number
- HK1172830A1 HK1172830A1 HK13100015.6A HK13100015A HK1172830A1 HK 1172830 A1 HK1172830 A1 HK 1172830A1 HK 13100015 A HK13100015 A HK 13100015A HK 1172830 A1 HK1172830 A1 HK 1172830A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- contrast agent
- dosage formulation
- ultrasound contrast
- agent dosage
- ultrasound
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210028040.8A CN102600485B (en) | 2004-06-04 | 2004-06-04 | Ultrasonic contrast medium dosage formula |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1172830A1 true HK1172830A1 (en) | 2013-05-03 |
Family
ID=46518500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13100015.6A HK1172830A1 (en) | 2004-06-04 | 2013-01-02 | Ultrasound contrast agent dosage formulation |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102600485B (en) |
HK (1) | HK1172830A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201791437A1 (en) | 2014-12-31 | 2017-12-29 | Лантеус Медикал Имэджинг, Инк. | COMPOSITIONS OF MICROSPHERE WITH GAS DISTRIBUTED IN LIPID AND RELATED METHODS |
US9789210B1 (en) | 2016-07-06 | 2017-10-17 | Lantheus Medical Imaging, Inc. | Methods for making ultrasound contrast agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ276167A (en) * | 1993-12-15 | 1996-11-26 | Bracco Research Sa | Ultrasound contrast medium comprising two gases in aqueous suspension |
US5837221A (en) * | 1996-07-29 | 1998-11-17 | Acusphere, Inc. | Polymer-lipid microencapsulated gases for use as imaging agents |
-
2004
- 2004-06-04 CN CN201210028040.8A patent/CN102600485B/en not_active Expired - Fee Related
-
2013
- 2013-01-02 HK HK13100015.6A patent/HK1172830A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN102600485A (en) | 2012-07-25 |
CN102600485B (en) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213897A0 (en) | Ultrasound contrast agent dosage formulation | |
IL186944A (en) | Solid dosage colonic purgative formulation and various aspects related thereto | |
IL185390A (en) | Solid pharmaceutical dosage formulation | |
HK1198914A1 (en) | Novel dosage formulation | |
IL177566A0 (en) | Pharmaceutical formulations | |
ZA200701557B (en) | Pharmaceutical compositions comprising diclofenac | |
EP2093237A4 (en) | Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient | |
GB0521139D0 (en) | Therapeutic agent | |
GB0426301D0 (en) | Pharmaceutical formulations | |
GB0615545D0 (en) | Therapeutic agent | |
IL178067A0 (en) | Pharmaceutical dosage forms and compositions | |
EP1819323A4 (en) | Pharmaceutical composition containing an anti-nucleating agent | |
GB0316206D0 (en) | Pharmaceutical formulation | |
GB0412530D0 (en) | Formulation | |
HK1105358A1 (en) | Solid pharmaceutical formulation | |
GB0416397D0 (en) | Pharmaceutical formulations | |
EP1757282A4 (en) | The use of kauranes compounds in the manufacture of medicament | |
HK1172830A1 (en) | Ultrasound contrast agent dosage formulation | |
IL189827A0 (en) | Pharmaceutical dosage forms and compositions comprising lecoztan | |
PL1688129T3 (en) | New therapeutic formulation | |
EP1908467A4 (en) | Herpesvirus-derived therapeutic agent for pain | |
GB0508153D0 (en) | Therapeutic agent | |
EP1900363A4 (en) | Therapeutic agent for pain | |
GB0406951D0 (en) | Improved formulation | |
GB0418270D0 (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190601 |